Table 1: Patients demographics.

Phase IaPhase Ib

Age, mean (min, max)64.2 (45, 83)64.7 (54, 80)
Male10 (76.9%)5 (71.4%)
Caucasian13 (100%)7 (100%)
Stage IV13 (100%)6 (85.7%)
Prior therapies
 Chemotherapy11 (84.6%)3 (42.9%)
 Immunotherapy9 (69.2%)6 (85.7%)
 Radiotherapy3 (23.1%)4 (57.1%)
 Surgery13 (100%)7 (100%)